Royal Bank Of Canada Raises Intuitive Surgical (NASDAQ:ISRG) Price Target to $650.00

Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by research analysts at Royal Bank Of Canada from $625.00 to $650.00 in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. The brokerage presently has an “outperform” rating on the medical equipment provider’s stock. Royal Bank Of Canada’s target price would suggest a potential upside of 17.21% from the company’s current price.

ISRG has been the subject of a number of other reports. HSBC lifted their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets raised their price target on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, BTIG Research raised their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $609.83.

Intuitive Surgical Stock Down 0.9%

NASDAQ ISRG opened at $554.58 on Wednesday. The company has a market cap of $198.81 billion, a PE ratio of 73.36, a price-to-earnings-growth ratio of 5.14 and a beta of 1.68. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm’s 50-day simple moving average is $534.09 and its two-hundred day simple moving average is $505.41.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter last year, the company earned $1.84 earnings per share. The company’s revenue was up 22.9% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares in the company, valued at $14,798,904.12. The trade was a 51.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 114,007 shares of company stock valued at $63,533,844. Corporate insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Brighton Jones LLC lifted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Colonial Trust Advisors increased its holdings in shares of Intuitive Surgical by 5,000.0% in the 1st quarter. Colonial Trust Advisors now owns 102 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 100 shares during the last quarter. Van Lanschot Kempen Investment Management N.V. raised its position in shares of Intuitive Surgical by 28.0% during the 1st quarter. Van Lanschot Kempen Investment Management N.V. now owns 30,635 shares of the medical equipment provider’s stock valued at $15,173,000 after buying an additional 6,702 shares in the last quarter. Vertex Planning Partners LLC lifted its holdings in shares of Intuitive Surgical by 5.3% during the 1st quarter. Vertex Planning Partners LLC now owns 896 shares of the medical equipment provider’s stock worth $444,000 after acquiring an additional 45 shares during the last quarter. Finally, Erste Asset Management GmbH grew its position in Intuitive Surgical by 6.5% in the first quarter. Erste Asset Management GmbH now owns 104,057 shares of the medical equipment provider’s stock worth $51,898,000 after acquiring an additional 6,381 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.